GlassScriptPhysician profile
Theresa Bryant
NPI 1205173424
$9,785.87
in general payments reported to CMS, 2019-2025
46 companies · $2,209 in 2025
The $2,209 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,622 · 2022: $3,039 · 2023: $1,531 · 2024: $1,385 · 2025: $2,209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,125.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,643.74 | 2022 | |
| Pfizer INC. | $884.34 | 2021-2025 | |
| Abbvie INC. | $860.09 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $796.06 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $757.81 | 2021-2025 | Jardiance |
| Lilly USA, LLC | $543.17 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $515.97 | 2022-2025 | |
| Glaxosmithkline, LLC. | $444.30 | 2021-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Novo Nordisk INC | $418.92 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Inspire Medical Systems, INC. | $315.82 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $239.30 | 2021-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $219.24 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $217.49 | 2022-2025 | Rexulti |
| Corcept Therapeutics | $181.65 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $159.21 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $140.74 | 2023 | Dyanavel Xr, Quillichew Er, Quillivant |
| Corium, LLC | $134.01 | 2022-2023 | Azstarys |
| Exact Sciences Corporation | $106.69 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.34 | 2021-2025 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $101.93 | 2021 | |
| Axsome Therapeutics, INC. | $93.02 | 2024-2025 | Auvelity |
| Amarin Pharma, INC. | $82.92 | 2021-2022 | |
| Abbott Laboratories | $80.88 | 2022-2024 | Freestyle Libre, Afinion 2 |
| Supernus Pharmaceuticals, INC. | $65.36 | 2021-2023 | Qelbree, Xyosted |
| Phathom Pharmaceuticals, INC. | $62.97 | 2024-2025 | Voquezna |
| Amgen INC. | $60.74 | 2022-2024 | Otezla, Repatha |
| Dexcom, INC. | $59.63 | 2024-2025 | Dexcom G6 Transmitter |
| Lundbeck LLC | $51.76 | 2025 | Rexulti, Vyepti |
| Ironshore Pharmaceuticals INC. | $44.51 | 2024 | |
| Novartis Pharmaceuticals Corporation | $44.48 | 2021 | |
| Eisai INC. | $39.99 | 2021-2022 | |
| Dynavax Technologies Corporation | $35.70 | 2024-2025 | Heplisav-B |
| Antares Pharma, INC. | $35.69 | 2023-2025 | Xyosted, Tlando, Nocdurna |
| Sanofi Pasteur INC. | $33.87 | 2022-2025 | |
| Stryker Corporation | $28.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Olympus America INC. | $25.57 | 2023 | Spiration Valve System |
| Halozyme INC | $19.26 | 2023 | |
| Globus Medical, INC. | $18.07 | 2025 | Senza |
| Ibsa Pharma INC. | $17.10 | 2023 | Tirosint, Licart |
| Medtronic, INC. | $15.42 | 2025 | Inceptiv |
| Idorsia Pharmaceuticals US INC | $15.26 | 2023 | Quviviq |
| Genentech USA, INC. | $14.25 | 2021 | |
| Tolmar, INC. | $14.20 | 2025 | Jatenzo |
| Ultragenyx Pharmaceutical INC. | $14.09 | 2023 | Crysvita |
| Collegium Pharmaceutical, INC. | $13.64 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theresa Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.